Status:
COMPLETED
PrEP Point-of-Care Brief-Intervention for Adherence Among Young Men Who Have Sex With Men
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
University of Miami
Conditions:
Risk Reduction
Eligibility:
MALE
18-30 years
Phase:
NA
Brief Summary
Despite advances in HIV prevention, the HIV incidence among young men who have sex with men (YMSM) is increasing, threatening to derail achievement of the United States End the HIV Epidemic goals. Alt...
Detailed Description
Young men who have sex with men (YMSM; ages 15-29 years) have rising HIV incidence in the United States. Pre-exposure prophylaxis (PrEP) is a highly effective medication prevent HIV infection, both at...
Eligibility Criteria
Inclusion
- Male sex at birth who has sex with men
- Age 18-30 years-old
- Currently receiving tenofovir-based oral PrEP
- Plans to continue taking daily PrEP over the upcoming 3 months
Exclusion
- Participant living with HIV
- Age \> 30 years
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05353283
Start Date
September 1 2023
End Date
July 1 2025
Last Update
October 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco/San Francisco General Hospital
San Francisco, California, United States, 94110